PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations
Authors:
Open Access
- 22 February 2025
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 44 (19) , 1336-1349
Abstract
Despite missense mutation accounts for over 60% of p53 alterations while homozygous deletion (HOM) for only 5% or less in advanced bladder cancer cases, most of the previously reported mouse models are deficient of p53. Accordingly, few studies have addressed the mechanisms of missense mutation occurrence and its functional advantage over HOM in bladder cancer development. Organoids derived from Krt5-expressing mouse urothelium (K5-mUrorganoid) demonstrated the crucial role of Pten loss in driving loss of wild-type allele of Trp53 (Trp53 R172H/LOH ), which conferred tumorigenic ability to K5-mUrorganoid in athymic mice. These tumors recapitulated the histological and genetic characteristics of the human basal-squamous subtype bladder cancer. Both Trp53 R172H/Δ ; Pten Δ/Δ and Trp53 Δ/Δ ; Pten Δ/Δ K5-mUrorganoids formed tumors in athymic mice, whereas only Trp53 R172H/Δ ; Pten Δ/Δ K5-mUrorganoid formed tumors even when directly inoculated in immunocompetent syngeneic mice. The absence of wild-type Trp53 was associated with upregulation of proliferative signaling, and the presence of a mutant Trp53 allele was associated with immune-excluded microenvironment. This study highlights the functional significance of p53 mutant LOH in bladder carcinogenesis conferring several hallmarks of cancer such as sustaining proliferative signaling and avoiding immune destruction, thus provides a novel immunocompetent mouse model of urothelial carcinoma harboring p53 mutations as a novel tool for cancer immunology research.Keywords
All Related Versions
Funding Information
- MEXT | Japan Society for the Promotion of Science (JP19H03790, JP22H03211, JP25713055)
- Princess Takamatsu Cancer Research Fund
- Kobayashi Foundation for Cancer Research
- Naito Foundation
- Uehara Memorial Foundation
This publication has 64 references indexed in Scilit:
- Crosstalk of Notch with p53 and p63 in cancer growth controlNature Reviews Cancer, 2009
- A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4Proceedings of the National Academy of Sciences, 2009
- Inactivation of p53 and Pten promotes invasive bladder cancerGenes & Development, 2009
- p53 represses c-Myc through induction of the tumor suppressor miR-145Proceedings of the National Academy of Sciences, 2009
- Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapyProceedings of the National Academy of Sciences, 2006
- p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle ArrestMolecular and Cellular Biology, 2005
- Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditionsCancer Biology & Therapy, 2005
- Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni SyndromeCell, 2004
- Role of NF-κB in p53-mediated programmed cell deathNature, 2000
- Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression.Molecular and Cellular Biology, 1993